Myasthenia gravis in children is caused by a disorder of neuromuscular synapse transmission with clinical manifestations of skeletal muscle weakness and fatigue. When suffering from this disease, children can suffer from systemic damage with symptoms of generalized myasthenia gravis, weak muscles that cannot breathe with effort, so they are susceptible to respiratory failure and death.

Myasthenia gravis is one of the autoimmune neuromuscular diseases that is more common in women. When suffering from this disease, the patient will encounter the problem of reducing the number of acetylcholine receptors at the motor endplate due to the attack of autoimmune antibodies on these receptors. If myasthenia gravis is not treated promptly, the risk of dangerous complications will be very high.

“Myasthenia gravis” is an autoimmune disease, usually accompanied by abnormalities in the thymus gland. If the body has symptoms of myasthenia gravis, it will produce a type of autoantibody against Ach, causing the amount of this substance in the body to decrease, and at the same time reducing the response of Ach receptors at the synaptic membrane.

Myasthenia gravis is an autoimmune neuromuscular disease. Current treatments are only symptomatic, inhibiting the progression of the disease but cannot cure the disease.